Angiogenic Factors and Cytokines in Diabetic Retinopathy.
about
Ocular Complications of Diabetes and Therapeutic ApproachesThe Vitreomacular Interface in Diabetic RetinopathyCandidate gene studies of diabetic retinopathy in humanMoving Past Anti-VEGF: Novel Therapies for Treating Diabetic RetinopathySerum fibroblast growth factor 21 levels are correlated with the severity of diabetic retinopathy.The role of microglia in diabetic retinopathyAngiogenic potential of vitreous from Proliferative Diabetic Retinopathy and Eales' Disease patients.Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.Comparison of aqueous concentrations of angiogenic and inflammatory cytokines based on optical coherence tomography patterns of diabetic macular edema.Dexamethasone implant in diabetic macular edema in real-life situationsImbalances in Mobilization and Activation of Pro-Inflammatory and Vascular Reparative Bone Marrow-Derived Cells in Diabetic Retinopathy.Placenta Growth Factor in Eyes with Neovascular Glaucoma Is Decreased after Intravitreal Ranibizumab InjectionExperimental study of the protective effects of SYVN1 against diabetic retinopathyMicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy.The small tellurium-based compound SAS suppresses inflammation in human retinal pigment epitheliumRole of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling.Niaspan inhibits diabetic retinopathy‑induced vascular inflammation by downregulating the tumor necrosis factor‑α pathway.Lentiviral vectors for cancer immunotherapy and clinical applicationsHepatitis C virus infection and insulin resistance.Protein kinase small molecule inhibitors for rheumatoid arthritis: Medicinal chemistry/clinical perspectives.Diabetic Retinopathy: Vascular and Inflammatory Disease.A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression.Microglia activation in a model of retinal degeneration and TUDCA neuroprotective effects.Enhanced endoplasmic reticulum stress in bone marrow angiogenic progenitor cells in a mouse model of long-term experimental type 2 diabetesDiabetic retinopathy: research to clinical practice.Diabetic Retinopathy and Laser Therapy in Rats: A Protein-Protein Interaction Network Analysis.Diagnostic enigmas of retinopathy: new dimensions.The reason for the amelioration of N-methyl-N-nitrosourea-induced retinitis pigmentosa in rats by hydrogen-rich saline.Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation.Sex-dependent independent prediction of incident diabetes by depressive symptoms.Elevated inflammatory cytokines in aqueous cytokine profile in HIV-1 infected patients with cataracts in Uganda.TRPV4 regulates migration and tube formation of human retinal capillary endothelial cells.Effects of thalidomide on growth and VEGF-A expression in SW480 colon cancer cells.A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
P2860
Q26749412-EE517203-6634-4520-AF3A-3FE8364C0275Q26783404-BDBC54DC-D5DE-4F11-812A-89D507975057Q28073127-5C67AC40-8626-4875-A7FC-7185E6FADA23Q28078199-771DF241-7112-454D-B59A-792079CA459FQ33563076-45F746E6-E5A2-44ED-9A6F-99496CF7BD61Q34199146-7C6E1792-0FC1-41C7-9552-7869391A2DB7Q34331514-9238CDEA-37DF-41D2-AF6D-B3FB787DDEEDQ35234189-9F3B395F-B88C-4B78-9D4E-FB9FF81EB6DCQ35717941-D16BFDCE-20B5-4781-9323-E32699282962Q35722473-6BED5FBD-D64C-47BD-8E22-E19160D3E622Q35854075-82D266BC-412F-42D8-AA66-D0D852C21736Q35892696-59A0AFDE-CF21-4E89-8DFB-894124F6C9F7Q35897929-88272E9B-079C-4F72-BA61-41A97B8C709DQ36273653-2AF449F4-2EDF-43CE-B787-99BD106620D3Q36937266-B71527EE-84B5-425C-82E4-92E4050DBBE8Q36956642-1459419E-504A-40F3-A4EC-773FEB0FA129Q37383408-BC4748DF-BFEF-431C-B2C7-4474B7E3E875Q37538552-EF9888C9-025E-401C-862C-E565AE33DE09Q37722105-142F36A4-FBDB-403A-88DD-5E6D98176371Q38147100-D5F5A05C-935C-4EBC-BCE7-276B6224EB06Q38190958-D2EF1752-F839-44B5-92BE-56A6A7DD8990Q38251801-6DEEDB4D-69EB-419E-9CB8-739DDC7DEF3AQ38542115-14F0F8BF-2C2F-43D2-8B22-70549B68AC9DQ39089813-9F64769D-6457-4736-AFAB-2710B32BF845Q41814116-6A593B37-4B3E-4A71-9536-0DF57E7F5F78Q42427071-86291C7F-2B1A-4396-A679-27E3DAAB0B38Q42672190-6DDBE4B3-BFBF-49DC-9935-3ECBE06570C8Q42699559-50C4A21C-2210-4DC6-9488-D5BF030E37E2Q42788064-F0126B9B-5ACF-4E8A-82E5-95C8E386737DQ43223993-314DFF2D-3E7E-4C8B-BE0F-5CC4C05E866FQ46087453-5B0BDC0E-41AE-4D28-A3C9-1D9B6FE19159Q48026371-E2CD7101-1BE0-45BB-83D2-37FE11AE32E5Q48205565-2421D811-4A54-4BC7-A722-9898DFDBD009Q49214793-ED05D08E-3B51-463C-8761-0206B8BB3C2DQ49513925-CF57E6F4-A6A6-4C20-B124-4E7CAF1BEB3CQ51503400-E809EE71-CAF1-4719-919D-8A8EDE0DD713Q51723573-0B8FBCA6-6CBD-42CE-A207-B4F71637B552
P2860
Angiogenic Factors and Cytokines in Diabetic Retinopathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Angiogenic Factors and Cytokines in Diabetic Retinopathy.
@en
type
label
Angiogenic Factors and Cytokines in Diabetic Retinopathy.
@en
prefLabel
Angiogenic Factors and Cytokines in Diabetic Retinopathy.
@en
P2860
P356
P1476
Angiogenic Factors and Cytokines in Diabetic Retinopathy.
@en
P2093
Steven F Abcouwer
P2860
P356
10.4172/2155-9899
P478
P577
2013-01-01T00:00:00Z